Alexion adds ex-Millennium CEO Dunsire to board amid activist pressure

Alexion Pharmaceuticals, a rare disease drugmaker that plans to move its headquarters to Boston later this year, has appointed former Millennium Pharmaceuticals CEO Deborah Dunsire to its board. The move, announced after markets closed on Monday, comes as Alexion (Nasdaq: ALXN) faces pressure from activist hedge fund Elliott Management to boost its share price and performance. Alexion announced in November that it was seeking a new board member to fill an empty seat. On Jan. 2 — a few weeks after…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news